|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Keio University, School of Medicine, Tokyo, Tokyo, Japan
2 Department of Anesthesiology6, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
3 Department of Pediatrics and Medicine, University of Utah, School of Medicine, Salt Lake City, UT, USA
4 Department of Molecular and Internal Medicine, Hiroshima University, Graduate School of Biomedical Science, Hiroshima, Hiroshima, Japan
5 Department of Anesthesiology, Keio University, School of Medicine, Tokyo, Tokyo, Japan
6 Department of Medicine and Anesthesia, University of California at San Francisco, Cardiovascular Research Institute, San Francisco, CA, USA
7 Department of Medicine, VA/Puget Sound Medical Center, Primary and Specialty Medicine Service Line, Seattle, WA, USA
* To whom correspondence should be addressed. E-mail: ishiz{at}attglobal.net.
KL-6 is a pulmonary epithelial mucin more prominently expressed on the surface membrane of alveolar type II cells when these cells are proliferating, stimulated and/or injured. We hypothesized that high levels of KL-6 in epithelial lining fluid and plasma would reflect the severity of lung injury in patients with acute lung injury (ALI). Epithelial lining fluid was obtained at onset (day 0) and day 1 of ARDS/ALI by bronchoscopic microsampling procedure in 35 patients. On day 0, KL-6 and albumin concentrations in epithelial lining fluid were significantly higher than in normal controls (P <0.001), and the concentrations of KL-6 in epithelial lining fluid (P <0.002) and in plasma (P <0.0001) were higher in non-survivors than in survivors of ALI/ARDS. These observations were corroborated by the immunohistochemical localization of KL-6 protein expression in the lungs of non-survivors with acute lung injury, and KL-6 secretion from cultured human alveolar type II cells stimulated by proinflammatory cytokines. Since injury to distal lung epithelial cells, including alveolar type II cells, is important in the pathogenesis of acute lung injury, the elevation of KL-6 concentrations in plasma and epithelial lining fluid could be valuable indicators for poor prognosis in clinical acute lung injury.
This article has been cited by other articles:
![]() |
M L Doan, O Elidemir, M K Dishop, H Zhang, E O Smith, P G Black, R R Deterding, D M Roberts, Q A Al-Salmi, and L L Fan Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism Thorax, August 1, 2009; 64(8): 677 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikuchi, J. Kikuchi, Y. Nasuhara, S. Oizumi, A. Ishizaka, and M. Nishimura Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2799 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury J Intensive Care Med, May 1, 2009; 24(3): 151 - 167. [Abstract] [PDF] |
||||
![]() |
D. J. Lederer, S. Jelic, R. C. Basner, A. Ishizaka, and J. Bhattacharya Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Eur. Respir. J., April 1, 2009; 33(4): 793 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Oue, M Hiroi, S Ogawa, S Hira, M Hasegawa, S Yamaoka, M Yasui, H Tamai, and T Ogihara Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): F17 - F22. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kipnis, K. Hansen, T. Sawa, K. Moriyama, A. Zurawel, A. Ishizaka, and J. Wiener-Kronish Proteomic Analysis of Undiluted Lung Epithelial Lining Fluid Chest, August 1, 2008; 134(2): 338 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zambon and J.-L. Vincent Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time Chest, May 1, 2008; 133(5): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Frank, R. Briot, J. W. Lee, A. Ishizaka, T. Uchida, and M. A. Matthay Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L52 - L59. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Miyazaki, S.-i. Nureki, E. Ono, M. Ando, O. Matsuno, T. Fukami, T. Ueno, and T. Kumamoto Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury Chest, June 1, 2007; 131(6): 1726 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tasaka, N. Hasegawa, S. Kobayashi, W. Yamada, T. Nishimura, T. Takeuchi, and A. Ishizaka Serum Indicators for the Diagnosis of Pneumocystis Pneumonia Chest, April 1, 2007; 131(4): 1173 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasabayashi, Y. Yamazaki, K. Tsushima, O. Hatayama, and T. Okabe Usefulness of Bronchoscopic Microsampling To Detect the Pathogenic Bacteria of Respiratory Infection Chest, February 1, 2007; 131(2): 474 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kotani, Y. Kotake, H. Morisaki, J. Takeda, H. Shimizu, T. Ueda, and A. Ishizaka Activation of a Neutrophil-Derived Inflammatory Response in the Airways During Cardiopulmonary Bypass Anesth. Analg., December 1, 2006; 103(6): 1394 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R L Medford and A B Millar Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax, July 1, 2006; 61(7): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Parsons Bridging the chasm between bench and bedside: translational research in acute lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1086 - L1087. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |